Request for Covid-19 Impact Assessment of this Report
The United States Mupirocin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mupirocin market, reaching US$ million by the year 2028. As for the Europe Mupirocin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Mupirocin players cover GSK, Medimetriks Pharmaceuticals, Cardinal Health, and Ortho-McNeil Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mupirocin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Cream
Ointment
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Primary Infection
Secondary Infection
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Medimetriks Pharmaceuticals
Cardinal Health
Ortho-McNeil Pharmaceutical
Glenmark Pharmaceuticals
Taro Pharmaceuticals
BIOMES PHARMACEUTICALS
H.J. Harkins Company
Directrx
Teva Pharmaceuticals
Fougera Pharmaceuticals
Profcient
Remedy Repack
Lohxa
Nucare Pharmaceuticals
Sino-american Tianjin Shike Pharmaceutical
Hangzhou Zhuyangxin Pharmaceutical
Hubei Renfu Chengtian Pharmaceutical
Hong Kong Aomei Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mupirocin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Mupirocin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Mupirocin by Country/Region, 2017, 2022 & 2028
2.2 Mupirocin Segment by Type
2.2.1 Cream
2.2.2 Ointment
2.2.3 Other
2.3 Mupirocin Sales by Type
2.3.1 Global Mupirocin Sales Market Share by Type (2017-2022)
2.3.2 Global Mupirocin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Mupirocin Sale Price by Type (2017-2022)
2.4 Mupirocin Segment by Application
2.4.1 Primary Infection
2.4.2 Secondary Infection
2.5 Mupirocin Sales by Application
2.5.1 Global Mupirocin Sale Market Share by Application (2017-2022)
2.5.2 Global Mupirocin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Mupirocin Sale Price by Application (2017-2022)
3 Global Mupirocin by Company
3.1 Global Mupirocin Breakdown Data by Company
3.1.1 Global Mupirocin Annual Sales by Company (2020-2022)
3.1.2 Global Mupirocin Sales Market Share by Company (2020-2022)
3.2 Global Mupirocin Annual Revenue by Company (2020-2022)
3.2.1 Global Mupirocin Revenue by Company (2020-2022)
3.2.2 Global Mupirocin Revenue Market Share by Company (2020-2022)
3.3 Global Mupirocin Sale Price by Company
3.4 Key Manufacturers Mupirocin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mupirocin Product Location Distribution
3.4.2 Players Mupirocin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Mupirocin by Geographic Region
4.1 World Historic Mupirocin Market Size by Geographic Region (2017-2022)
4.1.1 Global Mupirocin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Mupirocin Annual Revenue by Geographic Region
4.2 World Historic Mupirocin Market Size by Country/Region (2017-2022)
4.2.1 Global Mupirocin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Mupirocin Annual Revenue by Country/Region
4.3 Americas Mupirocin Sales Growth
4.4 APAC Mupirocin Sales Growth
4.5 Europe Mupirocin Sales Growth
4.6 Middle East & Africa Mupirocin Sales Growth
5 Americas
5.1 Americas Mupirocin Sales by Country
5.1.1 Americas Mupirocin Sales by Country (2017-2022)
5.1.2 Americas Mupirocin Revenue by Country (2017-2022)
5.2 Americas Mupirocin Sales by Type
5.3 Americas Mupirocin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mupirocin Sales by Region
6.1.1 APAC Mupirocin Sales by Region (2017-2022)
6.1.2 APAC Mupirocin Revenue by Region (2017-2022)
6.2 APAC Mupirocin Sales by Type
6.3 APAC Mupirocin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mupirocin by Country
7.1.1 Europe Mupirocin Sales by Country (2017-2022)
7.1.2 Europe Mupirocin Revenue by Country (2017-2022)
7.2 Europe Mupirocin Sales by Type
7.3 Europe Mupirocin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mupirocin by Country
8.1.1 Middle East & Africa Mupirocin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Mupirocin Revenue by Country (2017-2022)
8.2 Middle East & Africa Mupirocin Sales by Type
8.3 Middle East & Africa Mupirocin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mupirocin
10.3 Manufacturing Process Analysis of Mupirocin
10.4 Industry Chain Structure of Mupirocin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mupirocin Distributors
11.3 Mupirocin Customer
12 World Forecast Review for Mupirocin by Geographic Region
12.1 Global Mupirocin Market Size Forecast by Region
12.1.1 Global Mupirocin Forecast by Region (2023-2028)
12.1.2 Global Mupirocin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mupirocin Forecast by Type
12.7 Global Mupirocin Forecast by Application
13 Key Players Analysis
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Mupirocin Product Offered
13.1.3 GSK Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Medimetriks Pharmaceuticals
13.2.1 Medimetriks Pharmaceuticals Company Information
13.2.2 Medimetriks Pharmaceuticals Mupirocin Product Offered
13.2.3 Medimetriks Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Medimetriks Pharmaceuticals Main Business Overview
13.2.5 Medimetriks Pharmaceuticals Latest Developments
13.3 Cardinal Health
13.3.1 Cardinal Health Company Information
13.3.2 Cardinal Health Mupirocin Product Offered
13.3.3 Cardinal Health Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cardinal Health Main Business Overview
13.3.5 Cardinal Health Latest Developments
13.4 Ortho-McNeil Pharmaceutical
13.4.1 Ortho-McNeil Pharmaceutical Company Information
13.4.2 Ortho-McNeil Pharmaceutical Mupirocin Product Offered
13.4.3 Ortho-McNeil Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Ortho-McNeil Pharmaceutical Main Business Overview
13.4.5 Ortho-McNeil Pharmaceutical Latest Developments
13.5 Glenmark Pharmaceuticals
13.5.1 Glenmark Pharmaceuticals Company Information
13.5.2 Glenmark Pharmaceuticals Mupirocin Product Offered
13.5.3 Glenmark Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Glenmark Pharmaceuticals Main Business Overview
13.5.5 Glenmark Pharmaceuticals Latest Developments
13.6 Taro Pharmaceuticals
13.6.1 Taro Pharmaceuticals Company Information
13.6.2 Taro Pharmaceuticals Mupirocin Product Offered
13.6.3 Taro Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Taro Pharmaceuticals Main Business Overview
13.6.5 Taro Pharmaceuticals Latest Developments
13.7 BIOMES PHARMACEUTICALS
13.7.1 BIOMES PHARMACEUTICALS Company Information
13.7.2 BIOMES PHARMACEUTICALS Mupirocin Product Offered
13.7.3 BIOMES PHARMACEUTICALS Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 BIOMES PHARMACEUTICALS Main Business Overview
13.7.5 BIOMES PHARMACEUTICALS Latest Developments
13.8 H.J. Harkins Company
13.8.1 H.J. Harkins Company Company Information
13.8.2 H.J. Harkins Company Mupirocin Product Offered
13.8.3 H.J. Harkins Company Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 H.J. Harkins Company Main Business Overview
13.8.5 H.J. Harkins Company Latest Developments
13.9 Directrx
13.9.1 Directrx Company Information
13.9.2 Directrx Mupirocin Product Offered
13.9.3 Directrx Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Directrx Main Business Overview
13.9.5 Directrx Latest Developments
13.10 Teva Pharmaceuticals
13.10.1 Teva Pharmaceuticals Company Information
13.10.2 Teva Pharmaceuticals Mupirocin Product Offered
13.10.3 Teva Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Teva Pharmaceuticals Main Business Overview
13.10.5 Teva Pharmaceuticals Latest Developments
13.11 Fougera Pharmaceuticals
13.11.1 Fougera Pharmaceuticals Company Information
13.11.2 Fougera Pharmaceuticals Mupirocin Product Offered
13.11.3 Fougera Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Fougera Pharmaceuticals Main Business Overview
13.11.5 Fougera Pharmaceuticals Latest Developments
13.12 Profcient
13.12.1 Profcient Company Information
13.12.2 Profcient Mupirocin Product Offered
13.12.3 Profcient Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Profcient Main Business Overview
13.12.5 Profcient Latest Developments
13.13 Remedy Repack
13.13.1 Remedy Repack Company Information
13.13.2 Remedy Repack Mupirocin Product Offered
13.13.3 Remedy Repack Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Remedy Repack Main Business Overview
13.13.5 Remedy Repack Latest Developments
13.14 Lohxa
13.14.1 Lohxa Company Information
13.14.2 Lohxa Mupirocin Product Offered
13.14.3 Lohxa Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Lohxa Main Business Overview
13.14.5 Lohxa Latest Developments
13.15 Nucare Pharmaceuticals
13.15.1 Nucare Pharmaceuticals Company Information
13.15.2 Nucare Pharmaceuticals Mupirocin Product Offered
13.15.3 Nucare Pharmaceuticals Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Nucare Pharmaceuticals Main Business Overview
13.15.5 Nucare Pharmaceuticals Latest Developments
13.16 Sino-american Tianjin Shike Pharmaceutical
13.16.1 Sino-american Tianjin Shike Pharmaceutical Company Information
13.16.2 Sino-american Tianjin Shike Pharmaceutical Mupirocin Product Offered
13.16.3 Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Sino-american Tianjin Shike Pharmaceutical Main Business Overview
13.16.5 Sino-american Tianjin Shike Pharmaceutical Latest Developments
13.17 Hangzhou Zhuyangxin Pharmaceutical
13.17.1 Hangzhou Zhuyangxin Pharmaceutical Company Information
13.17.2 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product Offered
13.17.3 Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Hangzhou Zhuyangxin Pharmaceutical Main Business Overview
13.17.5 Hangzhou Zhuyangxin Pharmaceutical Latest Developments
13.18 Hubei Renfu Chengtian Pharmaceutical
13.18.1 Hubei Renfu Chengtian Pharmaceutical Company Information
13.18.2 Hubei Renfu Chengtian Pharmaceutical Mupirocin Product Offered
13.18.3 Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Hubei Renfu Chengtian Pharmaceutical Main Business Overview
13.18.5 Hubei Renfu Chengtian Pharmaceutical Latest Developments
13.19 Hong Kong Aomei Pharmaceutical
13.19.1 Hong Kong Aomei Pharmaceutical Company Information
13.19.2 Hong Kong Aomei Pharmaceutical Mupirocin Product Offered
13.19.3 Hong Kong Aomei Pharmaceutical Mupirocin Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Hong Kong Aomei Pharmaceutical Main Business Overview
13.19.5 Hong Kong Aomei Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Mupirocin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Mupirocin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Cream
Table 4. Major Players of Ointment
Table 5. Major Players of Other
Table 6. Global Mupirocin Sales by Type (2017-2022) & (KG)
Table 7. Global Mupirocin Sales Market Share by Type (2017-2022)
Table 8. Global Mupirocin Revenue by Type (2017-2022) & ($ million)
Table 9. Global Mupirocin Revenue Market Share by Type (2017-2022)
Table 10. Global Mupirocin Sale Price by Type (2017-2022) & (US$/G)
Table 11. Global Mupirocin Sales by Application (2017-2022) & (KG)
Table 12. Global Mupirocin Sales Market Share by Application (2017-2022)
Table 13. Global Mupirocin Revenue by Application (2017-2022)
Table 14. Global Mupirocin Revenue Market Share by Application (2017-2022)
Table 15. Global Mupirocin Sale Price by Application (2017-2022) & (US$/G)
Table 16. Global Mupirocin Sales by Company (2020-2022) & (KG)
Table 17. Global Mupirocin Sales Market Share by Company (2020-2022)
Table 18. Global Mupirocin Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Mupirocin Revenue Market Share by Company (2020-2022)
Table 20. Global Mupirocin Sale Price by Company (2020-2022) & (US$/G)
Table 21. Key Manufacturers Mupirocin Producing Area Distribution and Sales Area
Table 22. Players Mupirocin Products Offered
Table 23. Mupirocin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Mupirocin Sales by Geographic Region (2017-2022) & (KG)
Table 27. Global Mupirocin Sales Market Share Geographic Region (2017-2022)
Table 28. Global Mupirocin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Mupirocin Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Mupirocin Sales by Country/Region (2017-2022) & (KG)
Table 31. Global Mupirocin Sales Market Share by Country/Region (2017-2022)
Table 32. Global Mupirocin Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Mupirocin Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Mupirocin Sales by Country (2017-2022) & (KG)
Table 35. Americas Mupirocin Sales Market Share by Country (2017-2022)
Table 36. Americas Mupirocin Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Mupirocin Revenue Market Share by Country (2017-2022)
Table 38. Americas Mupirocin Sales by Type (2017-2022) & (KG)
Table 39. Americas Mupirocin Sales Market Share by Type (2017-2022)
Table 40. Americas Mupirocin Sales by Application (2017-2022) & (KG)
Table 41. Americas Mupirocin Sales Market Share by Application (2017-2022)
Table 42. APAC Mupirocin Sales by Region (2017-2022) & (KG)
Table 43. APAC Mupirocin Sales Market Share by Region (2017-2022)
Table 44. APAC Mupirocin Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Mupirocin Revenue Market Share by Region (2017-2022)
Table 46. APAC Mupirocin Sales by Type (2017-2022) & (KG)
Table 47. APAC Mupirocin Sales Market Share by Type (2017-2022)
Table 48. APAC Mupirocin Sales by Application (2017-2022) & (KG)
Table 49. APAC Mupirocin Sales Market Share by Application (2017-2022)
Table 50. Europe Mupirocin Sales by Country (2017-2022) & (KG)
Table 51. Europe Mupirocin Sales Market Share by Country (2017-2022)
Table 52. Europe Mupirocin Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Mupirocin Revenue Market Share by Country (2017-2022)
Table 54. Europe Mupirocin Sales by Type (2017-2022) & (KG)
Table 55. Europe Mupirocin Sales Market Share by Type (2017-2022)
Table 56. Europe Mupirocin Sales by Application (2017-2022) & (KG)
Table 57. Europe Mupirocin Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Mupirocin Sales by Country (2017-2022) & (KG)
Table 59. Middle East & Africa Mupirocin Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Mupirocin Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Mupirocin Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Mupirocin Sales by Type (2017-2022) & (KG)
Table 63. Middle East & Africa Mupirocin Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Mupirocin Sales by Application (2017-2022) & (KG)
Table 65. Middle East & Africa Mupirocin Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Mupirocin
Table 67. Key Market Challenges & Risks of Mupirocin
Table 68. Key Industry Trends of Mupirocin
Table 69. Mupirocin Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Mupirocin Distributors List
Table 72. Mupirocin Customer List
Table 73. Global Mupirocin Sales Forecast by Region (2023-2028) & (KG)
Table 74. Global Mupirocin Sales Market Forecast by Region
Table 75. Global Mupirocin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Mupirocin Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Mupirocin Sales Forecast by Country (2023-2028) & (KG)
Table 78. Americas Mupirocin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Mupirocin Sales Forecast by Region (2023-2028) & (KG)
Table 80. APAC Mupirocin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Mupirocin Sales Forecast by Country (2023-2028) & (KG)
Table 82. Europe Mupirocin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Mupirocin Sales Forecast by Country (2023-2028) & (KG)
Table 84. Middle East & Africa Mupirocin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Mupirocin Sales Forecast by Type (2023-2028) & (KG)
Table 86. Global Mupirocin Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Mupirocin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Mupirocin Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Mupirocin Sales Forecast by Application (2023-2028) & (KG)
Table 90. Global Mupirocin Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Mupirocin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Mupirocin Revenue Market Share Forecast by Application (2023-2028)
Table 93. GSK Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 94. GSK Mupirocin Product Offered
Table 95. GSK Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 96. GSK Main Business
Table 97. GSK Latest Developments
Table 98. Medimetriks Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 99. Medimetriks Pharmaceuticals Mupirocin Product Offered
Table 100. Medimetriks Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 101. Medimetriks Pharmaceuticals Main Business
Table 102. Medimetriks Pharmaceuticals Latest Developments
Table 103. Cardinal Health Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 104. Cardinal Health Mupirocin Product Offered
Table 105. Cardinal Health Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 106. Cardinal Health Main Business
Table 107. Cardinal Health Latest Developments
Table 108. Ortho-McNeil Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 109. Ortho-McNeil Pharmaceutical Mupirocin Product Offered
Table 110. Ortho-McNeil Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 111. Ortho-McNeil Pharmaceutical Main Business
Table 112. Ortho-McNeil Pharmaceutical Latest Developments
Table 113. Glenmark Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 114. Glenmark Pharmaceuticals Mupirocin Product Offered
Table 115. Glenmark Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 116. Glenmark Pharmaceuticals Main Business
Table 117. Glenmark Pharmaceuticals Latest Developments
Table 118. Taro Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 119. Taro Pharmaceuticals Mupirocin Product Offered
Table 120. Taro Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 121. Taro Pharmaceuticals Main Business
Table 122. Taro Pharmaceuticals Latest Developments
Table 123. BIOMES PHARMACEUTICALS Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 124. BIOMES PHARMACEUTICALS Mupirocin Product Offered
Table 125. BIOMES PHARMACEUTICALS Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 126. BIOMES PHARMACEUTICALS Main Business
Table 127. BIOMES PHARMACEUTICALS Latest Developments
Table 128. H.J. Harkins Company Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 129. H.J. Harkins Company Mupirocin Product Offered
Table 130. H.J. Harkins Company Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 131. H.J. Harkins Company Main Business
Table 132. H.J. Harkins Company Latest Developments
Table 133. Directrx Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 134. Directrx Mupirocin Product Offered
Table 135. Directrx Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 136. Directrx Main Business
Table 137. Directrx Latest Developments
Table 138. Teva Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 139. Teva Pharmaceuticals Mupirocin Product Offered
Table 140. Teva Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 141. Teva Pharmaceuticals Main Business
Table 142. Teva Pharmaceuticals Latest Developments
Table 143. Fougera Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 144. Fougera Pharmaceuticals Mupirocin Product Offered
Table 145. Fougera Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 146. Fougera Pharmaceuticals Main Business
Table 147. Fougera Pharmaceuticals Latest Developments
Table 148. Profcient Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 149. Profcient Mupirocin Product Offered
Table 150. Profcient Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 151. Profcient Main Business
Table 152. Profcient Latest Developments
Table 153. Remedy Repack Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 154. Remedy Repack Mupirocin Product Offered
Table 155. Remedy Repack Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 156. Remedy Repack Main Business
Table 157. Remedy Repack Latest Developments
Table 158. Lohxa Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 159. Lohxa Mupirocin Product Offered
Table 160. Lohxa Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 161. Lohxa Main Business
Table 162. Lohxa Latest Developments
Table 163. Nucare Pharmaceuticals Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 164. Nucare Pharmaceuticals Mupirocin Product Offered
Table 165. Nucare Pharmaceuticals Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 166. Nucare Pharmaceuticals Main Business
Table 167. Nucare Pharmaceuticals Latest Developments
Table 168. Sino-american Tianjin Shike Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 169. Sino-american Tianjin Shike Pharmaceutical Mupirocin Product Offered
Table 170. Sino-american Tianjin Shike Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 171. Sino-american Tianjin Shike Pharmaceutical Main Business
Table 172. Sino-american Tianjin Shike Pharmaceutical Latest Developments
Table 173. Hangzhou Zhuyangxin Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 174. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Product Offered
Table 175. Hangzhou Zhuyangxin Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 176. Hangzhou Zhuyangxin Pharmaceutical Main Business
Table 177. Hangzhou Zhuyangxin Pharmaceutical Latest Developments
Table 178. Hubei Renfu Chengtian Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 179. Hubei Renfu Chengtian Pharmaceutical Mupirocin Product Offered
Table 180. Hubei Renfu Chengtian Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 181. Hubei Renfu Chengtian Pharmaceutical Main Business
Table 182. Hubei Renfu Chengtian Pharmaceutical Latest Developments
Table 183. Hong Kong Aomei Pharmaceutical Basic Information, Mupirocin Manufacturing Base, Sales Area and Its Competitors
Table 184. Hong Kong Aomei Pharmaceutical Mupirocin Product Offered
Table 185. Hong Kong Aomei Pharmaceutical Mupirocin Sales (KG), Revenue ($ Million), Price (US$/G) and Gross Margin (2020-2022)
Table 186. Hong Kong Aomei Pharmaceutical Main Business
Table 187. Hong Kong Aomei Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Mupirocin
Figure 2. Mupirocin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mupirocin Sales Growth Rate 2017-2028 (KG)
Figure 7. Global Mupirocin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Mupirocin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Cream
Figure 10. Product Picture of Ointment
Figure 11. Product Picture of Other
Figure 12. Global Mupirocin Sales Market Share by Type in 2021
Figure 13. Global Mupirocin Revenue Market Share by Type (2017-2022)
Figure 14. Mupirocin Consumed in Primary Infection
Figure 15. Global Mupirocin Market: Primary Infection (2017-2022) & (KG)
Figure 16. Mupirocin Consumed in Secondary Infection
Figure 17. Global Mupirocin Market: Secondary Infection (2017-2022) & (KG)
Figure 18. Global Mupirocin Sales Market Share by Application (2017-2022)
Figure 19. Global Mupirocin Revenue Market Share by Application in 2021
Figure 20. Mupirocin Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Mupirocin Revenue Market Share by Company in 2021
Figure 22. Global Mupirocin Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Mupirocin Revenue Market Share by Geographic Region in 2021
Figure 24. Global Mupirocin Sales Market Share by Region (2017-2022)
Figure 25. Global Mupirocin Revenue Market Share by Country/Region in 2021
Figure 26. Americas Mupirocin Sales 2017-2022 (KG)
Figure 27. Americas Mupirocin Revenue 2017-2022 ($ Millions)
Figure 28. APAC Mupirocin Sales 2017-2022 (KG)
Figure 29. APAC Mupirocin Revenue 2017-2022 ($ Millions)
Figure 30. Europe Mupirocin Sales 2017-2022 (KG)
Figure 31. Europe Mupirocin Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Mupirocin Sales 2017-2022 (KG)
Figure 33. Middle East & Africa Mupirocin Revenue 2017-2022 ($ Millions)
Figure 34. Americas Mupirocin Sales Market Share by Country in 2021
Figure 35. Americas Mupirocin Revenue Market Share by Country in 2021
Figure 36. United States Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Mupirocin Sales Market Share by Region in 2021
Figure 41. APAC Mupirocin Revenue Market Share by Regions in 2021
Figure 42. China Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Mupirocin Sales Market Share by Country in 2021
Figure 49. Europe Mupirocin Revenue Market Share by Country in 2021
Figure 50. Germany Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Mupirocin Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Mupirocin Revenue Market Share by Country in 2021
Figure 57. Egypt Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Mupirocin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Mupirocin in 2021
Figure 63. Manufacturing Process Analysis of Mupirocin
Figure 64. Industry Chain Structure of Mupirocin
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...